Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
398. lappuse
... Chromatography ( a ) Equipment- ( 1 ) tank . A rectangular tank , approxi- mately 9 × 9 × 3.5 inches lined with Whatman's 3MM chromatographic paper ( 0.3 millimeters ) or equivalent . ( 2 ) Iodine vapor chamber . A rectangu- lar tank ...
... Chromatography ( a ) Equipment- ( 1 ) tank . A rectangular tank , approxi- mately 9 × 9 × 3.5 inches lined with Whatman's 3MM chromatographic paper ( 0.3 millimeters ) or equivalent . ( 2 ) Iodine vapor chamber . A rectangu- lar tank ...
401. lappuse
... chromatographic identity test for hetacillin . ( a ) Equipment- ( 1 ) Chromatography tank . A rectangular tank , approxi- mately 9 × 9 × 3.5 inches with a glass solvent trough on the bottom . ( 2 ) Plates . Use 20 × 20 centimeter thin ...
... chromatographic identity test for hetacillin . ( a ) Equipment- ( 1 ) Chromatography tank . A rectangular tank , approxi- mately 9 × 9 × 3.5 inches with a glass solvent trough on the bottom . ( 2 ) Plates . Use 20 × 20 centimeter thin ...
403. lappuse
... chromatography iden- tity test for tetracyclines . ( a ) Equipment— ( 1 ) Sheet ( chromatographic ) . Whatman No. 1 filter paper for chromatography , 20 × 20 cen- timeters . ( 2 ) Chamber ( chromatographic ) . Cylin- drical glass ...
... chromatography iden- tity test for tetracyclines . ( a ) Equipment— ( 1 ) Sheet ( chromatographic ) . Whatman No. 1 filter paper for chromatography , 20 × 20 cen- timeters . ( 2 ) Chamber ( chromatographic ) . Cylin- drical glass ...
405. lappuse
... chromatographic tube by increments and firmly tamp down each increment . Do not use any glass wool in the column outlet . Add enough support phase to the column to reach a height of 9 to 11 centimeters ; then add 1 milliliter of sample ...
... chromatographic tube by increments and firmly tamp down each increment . Do not use any glass wool in the column outlet . Add enough support phase to the column to reach a height of 9 to 11 centimeters ; then add 1 milliliter of sample ...
407. lappuse
... chromatography plates coat- ed with silica gel G or equivalent , to a thickness of 250 microns . ( b ) Reagents- ( 1 ) ... chromatographic paper ( 0.33 millime- ters ) or equivalent . ( 2 ) Plates . Use 20- by 20 - centimeter thin layer ...
... chromatography plates coat- ed with silica gel G or equivalent , to a thickness of 250 microns . ( b ) Reagents- ( 1 ) ... chromatographic paper ( 0.33 millime- ters ) or equivalent . ( 2 ) Plates . Use 20- by 20 - centimeter thin layer ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning